Insulin, the IGF Axis, and Colorectal Neoplasia
Insulin, the IGF Axis, and Colorectal Neoplasia
批准号:
6693396
负责人:
PAUL J LIMBURG
金额:
$12.54万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-07-01 至 2006-06-30
关键词:
adenocarcinomabinding proteinscancer riskclinical researchcolorectal neoplasmsgenetic polymorphismhormone regulation /control mechanismhuman subjectinsulininsulin receptorinsulinlike growth factorintestinal mucosaneoplasm /cancer epidemiologyneoplasm /cancer geneticsnoninsulin dependent diabetes mellitussmokingtobacco abuse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The Cancer Prevention, Control, and
Population Sciences Career Development Award will provide an excellent
opportunity for me to acquire and refine the skills necessary to conduct
high-quality gastrointestinal cancer prevention research at a population
level. My proposed research plan involves the rigorous evaluation of a timely
central hypothesis with direct relevance to colorectal cancer prevention.
Using a series of different general, molecular, and genetic epidemiologic
approaches, I intend to explore unresolved or unexamined issues related to the
possibility that hyperinsulinemia, either alone or in combination with
insulin-like growth factor (IGF) axis proteins, is causally linked to
colorectal carcinogenesis. Existing data from cell culture experiments,
animal model systems, and human observational studies support this hypothesis,
yet many essential questions remain to be addressed. In the context of
mentored research, I plan to perform (1) a historical cohort study of type 2
diabetes mellitus (DM) and colorectal adenocarcinoma risk, (2) a case-control
study of type 2 DM and colorectal adenoma risk, (3) a nested case-control
study of serum insulin/IGF axis protein concentrations and colorectal
adenocarcinoma risk, (4) a pilot study of IGF axis mRNA expression levels in
neoplastic versus non-neoplastic colorectal mucosa, and (5) a prospective
cohort study of IGF axis gene polymorphisms among subjects with or without
colorectal neoplasia. These studies should provide meaningful scientific
data, while simultaneously affording me a broad exposure to and considerable
experience with several important investigational tools. To further enhance
my career development, I plan to obtain didactic training in areas relevant to
gastrointestinal cancer prevention research (including the responsible conduct
of research). Additionally, I intend to serve as an instructor for a cancer
epidemiology course at Mayo Graduate School. The resources of my sponsoring
institution are excellent and will facilitate the successful, efficient
completion of my overall objectives. Following achievement of these goals, I
am confident that I will be ready to continue my career as a successful
independent investigator committed to academic research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IGF::OT::IGF IGF CORE INFRASTRUCTURE SUPPORT
-
批准号:9162606
-
项目类别:
-
资助金额:$79.77万
-
财政年份:2015
-
负责人:PAUL J LIMBURG
-
依托单位:
IGF::OT::IGF IGF CORE INFRASTRUCTURE SUPPORT
-
批准号:9217520
-
项目类别:
-
资助金额:$84.29万
-
财政年份:2015
-
负责人:PAUL J LIMBURG
-
依托单位:
CORE INFRASTRUCTURE SUPPORT
-
批准号:9554735
-
项目类别:
-
资助金额:$85.53万
-
财政年份:2015
-
负责人:PAUL J LIMBURG
-
依托单位:
CONTRACTOR: MAYO CLINIC; DUNNS: 006471700; PILOT STUDY OF EGFR INHIBITION WITH ERLOTINIB IN CIRRHOSIS TO INHIBIT FIRBROGENESIS AND PREVENT HEPATOCELLULAR CARCINOMA HHSN261201200042I; TASK ORDER HHSN26
-
批准号:8948670
-
项目类别:
-
资助金额:$47.17万
-
财政年份:2014
-
负责人:PAUL J LIMBURG
-
依托单位:
HHSB26120120000421 DOSE-DE ESCALATION/ESCALAATION TRIAL TO IDENTIFY THE LOWEST COMMERCIALLY AVAILABLE DOSE OF LINACLOTIDE THAT MAINTAINS BIOACTIVITY IN RECTAL MUCOSA (PROTOCOL MAY2012-00-01 09/24/201
-
批准号:8948664
-
项目类别:
-
资助金额:$20.98万
-
财政年份:2014
-
负责人:PAUL J LIMBURG
-
依托单位:
PHASEI/II TRIAL OF A THERAPEUTIC DNA VACCINE FOR CHRONIC HEPATITIS C VIRUS (HCV) INFECTION;
-
批准号:9918807
-
项目类别:
-
资助金额:$8.47万
-
财政年份:2014
-
负责人:PAUL J LIMBURG
-
依托单位:
CONTRACTOR: MAYO CLINIC; DUNNS: 006471700; PHASEI/II TRIAL OF A THERAPEUTIC DNA VACCINE FOR CHRONIC HEPATITIS C VIRUS (HCV) INFECTION;HHSN261201200042I; TASK ORDER HHSN26100006; 09/09/2014 09/08/2016
-
批准号:9507737
-
项目类别:
-
资助金额:$8.68万
-
财政年份:2014
-
负责人:PAUL J LIMBURG
-
依托单位:
Molecular Epidemiology of Colorectal Cancer Subtypes
-
批准号:6966760
-
项目类别:
-
资助金额:$28.74万
-
财政年份:2005
-
负责人:PAUL J LIMBURG
-
依托单位:
Molecular Epidemiology of Colorectal Cancer Subtypes
-
批准号:7643948
-
项目类别:
-
资助金额:$19.09万
-
财政年份:2005
-
负责人:PAUL J LIMBURG
-
依托单位:
Molecular Epidemiology of Colorectal Cancer Subtypes
-
批准号:7122544
-
项目类别:
-
资助金额:$38.35万
-
财政年份:2005
-
负责人:PAUL J LIMBURG
-
依托单位:
Molecular Epidemiology of Colorectal Cancer Subtypes
-
批准号:7869345
-
项目类别:
-
资助金额:$7.6万
-
财政年份:2005
-
负责人:PAUL J LIMBURG
-
依托单位:
Molecular Epidemiology of Colorectal Cancer Subtypes
-
批准号:7277762
-
项目类别:
-
资助金额:$14.05万
-
财政年份:2005
-
负责人:PAUL J LIMBURG
-
依托单位:
Molecular Epidemiology of Colorectal Cancer Subtypes
-
批准号:7496492
-
项目类别:
-
资助金额:$32.69万
-
财政年份:2005
-
负责人:PAUL J LIMBURG
-
依托单位:
Pre-Endoscopy Survey of Risk Factors for GI Conditions
-
批准号:7042322
-
项目类别:
-
资助金额:$1.18万
-
财政年份:2003
-
负责人:PAUL J LIMBURG
-
依托单位:
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
-
批准号:8339911
-
项目类别:
-
资助金额:$219.6万
-
财政年份:2003
-
负责人:PAUL J LIMBURG
-
依托单位:
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
-
批准号:7943307
-
项目类别:
-
资助金额:$207.1万
-
财政年份:2003
-
负责人:PAUL J LIMBURG
-
依托单位:
PHASE 1 AND PHASE 2 CLINICAL TRIALS OF CANCER CHEMOPREVENTIVE AGENTS
-
批准号:7543354
-
项目类别:
-
资助金额:$225.77万
-
财政年份:2003
-
负责人:PAUL J LIMBURG
-
依托单位:--
Insulin, the IGF Axis, and Colorectal Neoplasia
-
批准号:6848272
-
项目类别:
-
资助金额:$12.54万
-
财政年份:2001
-
负责人:PAUL J LIMBURG
-
依托单位:
Insulin, the IGF Axis, and Colorectal Neoplasia
-
批准号:6515182
-
项目类别:
-
资助金额:$6.27万
-
财政年份:2001
-
负责人:PAUL J LIMBURG
-
依托单位:
Insulin, the IGF Axis, and Colorectal Neoplasia
-
批准号:6365783
-
项目类别:
-
资助金额:$12.54万
-
财政年份:2001
-
负责人:PAUL J LIMBURG
-
依托单位:
海外基金